Picture of Pcas SA logo

PCA Pcas SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeSmall Cap

Brief: PCAS Net Loss Widens To EUR 48.8 Million

March 30 (Reuters) - Pcas SA  PCAS.PA :
    * FY NET LOSS EUR 48.8 MILLION VERSUS LOSS EUR 40.5 MILLION
YEAR
AGO
    * FY EBITDA EUR 2.2 MILLION VERSUS EBITDA LOSS EUR 4.6
MILLION
YEAR AGO
    * FY NET SALES EUR 226.4 MILLION VERSUS EUR 187.0 MILLION
YEAR AGO
    * IN CONTEXT OF CURRENT DISPUTE WITH MITHRA, PCAS HAS NO
OPTION
BUT TO CONSIDER A TEMPORARY REDUCTION OF ACTIVITY IN 2023 AT
PRODUCTION SITE CONCERNED, SINCE SOME OF ITS WORKSHOPS ARE
DEDICATED TO PRODUCTION OF ESTETROL
    * AT THIS STAGE, IT IS NOT POSSIBLE TO ACCURATELY ASSESS
CONSEQUENCES THIS DISPUTE MAY HAVE ON FUTURE BUSINESS FORECASTS
AND RESULTS
    * CONSEQUENTLY, RETURN TO POSITIVE RESULTS ANNOUNCED FOR
2023 IS
POSTPONED

Source text for Eikon:  ID:nGNE3Q66Z9 
Further company coverage:  PCAS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Pcas SA

See all news